Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical 0.5% Timolol Maleate for Chronic Heel Recalcitrant Fissures
IRCT20230712058759N1Phase 2Completed
- Sponsor
- Pak Emirates Military Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of timolol in heel fissure and dermatitis, sponsored by Pak Emirates Military Hospital. Started Jun 2023; status: completed.
02
Drugs
timolol
03
Conditions
heel fissuredermatitis
Beyond the preview
Go deeper on IRCT20230712058759N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230712058759N1.